6.
Huo X, Han S, Wu G, Latchoumanin O, Zhou G, Hebbard L
. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Mol Cancer. 2017; 16(1):165.
PMC: 5651571.
DOI: 10.1186/s12943-017-0734-4.
View
7.
Subramaniam N, Nair R, Marsden P
. Epigenetic Regulation of the Vascular Endothelium by Angiogenic LncRNAs. Front Genet. 2021; 12:668313.
PMC: 8427604.
DOI: 10.3389/fgene.2021.668313.
View
8.
Veith A, Henderson K, Spencer A, Sligar A, Baker A
. Therapeutic strategies for enhancing angiogenesis in wound healing. Adv Drug Deliv Rev. 2018; 146:97-125.
PMC: 6435442.
DOI: 10.1016/j.addr.2018.09.010.
View
9.
Schonborn M, Laczak P, Pasieka P, Borys S, Plotek A, Maga P
. Pro- and Anti-Angiogenic Factors: Their Relevance in Diabetic Foot Syndrome-A Review. Angiology. 2021; 73(4):299-311.
DOI: 10.1177/00033197211042684.
View
10.
Luo H, Li G, Liu Y, Wei Y, Chen J, Gu X
. The Accelerated Progression of Atherosclerosis Correlates with Decreased miR-33a and miR-21 and Increased miR-122 and miR-3064-5p in Circulation and the Liver of ApoE-/- Mice with Streptozocin (STZ)-Induced Type 2 Diabetes. Curr Issues Mol Biol. 2022; 44(10):4822-4837.
PMC: 9601109.
DOI: 10.3390/cimb44100328.
View
11.
Teena R, Dhamodharan U, Ali D, Rajesh K, Ramkumar K
. Gene Expression Profiling of Multiple Histone Deacetylases () and Its Correlation with -Mediated Redox Regulation in the Pathogenesis of Diabetic Foot Ulcers. Biomolecules. 2020; 10(10).
PMC: 7589955.
DOI: 10.3390/biom10101466.
View
12.
Pandey A, Ajgaonkar S, Jadhav N, Saha P, Gurav P, Panda S
. Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. Pharmaceuticals (Basel). 2022; 15(10).
PMC: 9610703.
DOI: 10.3390/ph15101269.
View
13.
Onodera K, Shavit J, Motohashi H, Yamamoto M, Engel J
. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. EMBO J. 2000; 19(6):1335-45.
PMC: 305674.
DOI: 10.1093/emboj/19.6.1335.
View
14.
Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F
. Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer. Mol Cancer. 2015; 14:191.
PMC: 4640217.
DOI: 10.1186/s12943-015-0455-5.
View
15.
Jayasuriya R, Ganesan K, Xu B, Ramkumar K
. Emerging role of long non-coding RNAs in endothelial dysfunction and their molecular mechanisms. Biomed Pharmacother. 2021; 145:112421.
DOI: 10.1016/j.biopha.2021.112421.
View
16.
Prinz F, Kapeller A, Pichler M, Klec C
. The Implications of the Long Non-Coding RNA in Non-Cancerous Diseases. Int J Mol Sci. 2019; 20(3).
PMC: 6387324.
DOI: 10.3390/ijms20030627.
View
17.
Ghafouri-Fard S, Taheri M
. Nuclear Enriched Abundant Transcript 1 (NEAT1): A long non-coding RNA with diverse functions in tumorigenesis. Biomed Pharmacother. 2018; 111:51-59.
DOI: 10.1016/j.biopha.2018.12.070.
View
18.
Wu H, Li F, Shao W, Gao J, Ling D
. Promoting Angiogenesis in Oxidative Diabetic Wound Microenvironment Using a Nanozyme-Reinforced Self-Protecting Hydrogel. ACS Cent Sci. 2019; 5(3):477-485.
PMC: 6439452.
DOI: 10.1021/acscentsci.8b00850.
View
19.
Jayasuriya R, Ramkumar K
. Mangiferin alleviates hyperglycemia-induced endothelial impairment via Nrf2 signaling pathway. Eur J Pharmacol. 2022; 936:175359.
DOI: 10.1016/j.ejphar.2022.175359.
View
20.
Dong S, Xiong W, Yuan J, Li J, Liu J, Xu X
. MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-κB expression. Mol Med Rep. 2013; 8(2):407-12.
DOI: 10.3892/mmr.2013.1538.
View